Goldman Sachs
AIH

Goldman Sachs’s Aesthetic Medical International Holdings AIH Stock Holding History

Goldman Sachs’s Portfolio AIH Stock Details AIH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-16,726
Closed -$123K – 6596
2021
Q1 		$123K Buy
+16,726
New +$108K ﹤0.01% 5782

Other funds holding AIH

IACGFIA
IDG-Accel China Growth Fund III Associates Hong Kong $31.2M AUM 2.97% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Goldman Sachs's AIH Position: Q2 2021 in Review

Goldman Sachs sold out of Aesthetic Medical International Holdings (AIH) in Q2 2021, closing a stake of 16,726 shares — an estimated $123K sold.

Goldman Sachs first reported a position in AIH in Q1 2021 and held it in 1 quarter. The position peaked at $123K in Q1 2021. 6 funds tracked by Wall St. Rank hold AIH as of Q2 2021.

  • Goldman Sachs reported no remaining Aesthetic Medical International Holdings position as of Q2 2021 after selling out during the quarter.
  • Goldman Sachs sold 16,726 Aesthetic Medical International Holdings shares in Q2 2021, an estimated $123K.
  • Goldman Sachs first reported a position in Aesthetic Medical International Holdings in Q1 2021 and held it in 1 quarter.
  • Goldman Sachs's Aesthetic Medical International Holdings position peaked at $123K in Q1 2021.
  • 6 funds tracked by Wall St. Rank held Aesthetic Medical International Holdings as of Q2 2021.

Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.